Simi Valley attracts corporate HQs
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Capsida furthers its deal with AbbVie
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Officials gather to discuss options available to the public following storm
With the near-record storm behind the Central Coast, all that is left now is to pick up the pieces. The Federal Emergency Management Agency (FEMA) and the Small Business Administration (SBA) have been the ones trying to accomplish that goal, teaming up to provide the tri-counties with a slew of help. “Partnering with FEMA and Read More →
Dole plc sells off fresh vegetables division for $293M
In a continued effort to pay down its debt, Westlake Village-based Dole plc has sold off its fresh vegetables division to an affiliate of Fresh Express Inc., a wholly-owned subsidiary of Chiquita Holdings, for $293 million. The sale is expected to close within the next two quarters, pending approval, Dole said in a press release. Read More →
Amgen to lay off 300 U.S. workers
Technology layoffs are now hitting the healthcare sector, as Amgen will be laying off 300 people in the United States, the company announced on Jan. 30. The Thousand Oaks-based biotechnology giant said that it is making organizational changes “mainly in our commercial team,” the company’s statement said. “We made these changes to better manage against Read More →
Teledyne caps off strong year with record-breaking fourth quarter
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Arcutis share up after earnings report; company reports mounting losses but progress toward FDA approval
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
